147 related articles for article (PubMed ID: 20367108)
1. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage.
Pieper IA; Bertau M
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):747-60. PubMed ID: 20367108
[TBL] [Abstract][Full Text] [Related]
2. Mitigating permeability-mediated risks in drug discovery.
Wang J; Skolnik S
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):171-87. PubMed ID: 20064074
[TBL] [Abstract][Full Text] [Related]
3. The gastrointestinal microbiota as a site for the biotransformation of drugs.
Sousa T; Paterson R; Moore V; Carlsson A; Abrahamsson B; Basit AW
Int J Pharm; 2008 Nov; 363(1-2):1-25. PubMed ID: 18682282
[TBL] [Abstract][Full Text] [Related]
4. In silico methods for early toxicity assessment.
Merlot C
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in physicochemical and ADMET profiling in drug discovery.
Wang J; Skolnik S
Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
[TBL] [Abstract][Full Text] [Related]
6. Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications.
Baumann A; Karst U
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):715-31. PubMed ID: 20370599
[TBL] [Abstract][Full Text] [Related]
7. Use of intrinsic clearance for prediction of human hepatic clearance.
Chao P; Uss AS; Cheng KC
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
[TBL] [Abstract][Full Text] [Related]
8. From known knowns to known unknowns: predicting in vivo drug metabolites.
Pelkonen O; Tolonen A; Korjamo T; Turpeinen M; Raunio H
Bioanalysis; 2009 May; 1(2):393-414. PubMed ID: 21083174
[TBL] [Abstract][Full Text] [Related]
9. A role for CYP in the drug-hormone crosstalk of the brain.
Meyer RP; Gehlhaus M
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):675-87. PubMed ID: 20201748
[TBL] [Abstract][Full Text] [Related]
10. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
11. Integrating metabolism and toxicity in multi-organ systems.
Madden S; Bach PH
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):66-72. PubMed ID: 11727325
[TBL] [Abstract][Full Text] [Related]
12. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
Srinivas NR
Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. The challenge of predicting drug toxicity in silico.
Vedani A; Dobler M; Lill MA
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):195-208. PubMed ID: 16930291
[TBL] [Abstract][Full Text] [Related]
15. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
Dokoumetzidis A; Kalantzi L; Fotaki N
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
17. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
18. Resolving intraluminal drug and formulation behavior: Gastrointestinal concentration profiling in humans.
Brouwers J; Augustijns P
Eur J Pharm Sci; 2014 Sep; 61():2-10. PubMed ID: 24495579
[TBL] [Abstract][Full Text] [Related]
19. Predicting circulating human metabolites: how good are we?
Anderson S; Luffer-Atlas D; Knadler MP
Chem Res Toxicol; 2009 Feb; 22(2):243-56. PubMed ID: 19138063
[TBL] [Abstract][Full Text] [Related]
20. Emerging applications of kinetic biomarkers in preclinical and clinical drug development.
Turner SM; Hellerstein MK
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):115-26. PubMed ID: 15679179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
